Dr. Dennis Slamon, an oncologist and researcher at the UCLA Health Jonsson Comprehensive Cancer Center, has won the 2026 Albany Prize alongside Dr. Tony Hunter of the Salk Institute for Biological Studies, News-Medical reported. The award recognizes breakthroughs in cancer biology that revealed molecular mechanisms driving tumors and produced lifesaving treatments for millions. Slamon shares … Read more
Research examines the host range and related antigenicity of multiple bat coronaviruses interacting with angiotensin-converting enzyme 2 (ACE2). Clade 1 viruses demonstrate broad generalist receptor usage across diverse mammalian receptor libraries, indicating a predictable pattern for host range and antigenic relatedness across bat sarbecoviruses. Thakur, J. Newman, D. Ni, J. Seow, A. L. Hay, Y. … Read more
Adults aged 50 and older have a new option for fall immunization after the U.S. Produced by Moderna, the shot uses lipid particles to deliver mRNA sequences into human cells, instructing them to temporarily produce a harmless hemagglutinin protein to stimulate an immune response against circulating influenza strains. How the mRNA Flu Vaccine Works Compared … Read more
_6e98296023b34dfabc133638c1ef5d32-620x480.jpg)
Humanized antibodies targeting the Nav1.7 sodium ion channel provide long-lasting relief from neuropathic pain in preclinical rat models while preserving normal pain sensation and motor function, according to a study published on June 21, 2026, in Volume 18 of Pharmaceutics. Researchers led by Associate Professor Daisuke Uta of the University of Toyama and Dr. Sosuke … Read more
Researchers at the Indian Institute of Science and the Technical University of Denmark have developed a recombinant, nanobody-based antivenom that neutralizes venom from geographically diverse cobra and king cobra species in India, according to a study published in Science Translational Medicine. India reports nearly 50,000 snakebite deaths every year, representing the highest mortality toll from … Read more
New research published in the journal Cell reveals that severe COVID-19 cases are often linked to a pre-existing immune defect where the body produces autoantibodies that neutralize type I interferons. According to findings from an international team of scientists, these autoantibodies are the result of a mature B-cell response that disables the body’s primary antiviral … Read more
Researchers at Sungkyunkwan University (SKKU), in collaboration with the Catholic University of Korea and Eunpyeong St. Mary’s Hospital, have developed an ultrasensitive electrochemical biosensor capable of detecting early-stage liver fibrosis through a small blood sample. The device, known as FIB-EIS, identifies the protein PICP to signal liver hardening, potentially replacing invasive tissue biopsies with a … Read more
Exclusive breastfeeding for up to six months is associated with a lower risk of ADHD symptoms in children between the ages of three and eight, according to a study published in Biological Psychiatry. Researchers from the University of Bergen analyzed data from 37,600 families in the Norwegian Mother, Father and Child Cohort Study (MoBa) to … Read more
MIT engineers have developed a novel, gel-based drug delivery system designed to coat the esophageal lining and transport medication directly into the tissue. By utilizing a hydrogel combined with permeability-enhancing bile salts, this approach aims to treat disorders like eosinophilic esophagitis and Crohn’s disease while avoiding the systemic side effects of traditional immunosuppressant drugs, according … Read more
Scripps Research scientists have developed a vaccine candidate designed to neutralize a broad class of fentanyl-related synthetic opioids by targeting a shared molecular fingerprint. According to research published in the Journal of Medicinal Chemistry on May 12, 2026, the vaccine may protect against various designer drugs while leaving therapeutic medical opioids like morphine unaffected. How … Read more